• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核Nrf2易位受损会破坏弗里德赖希共济失调中的氧化应激反应。

Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.

作者信息

Paupe Vincent, Dassa Emmanuel P, Goncalves Sergio, Auchère Françoise, Lönn Maria, Holmgren Arne, Rustin Pierre

机构信息

Inserm, U676, Hôpital Robert Debré, Bât. Ecran, Paris, France.

出版信息

PLoS One. 2009;4(1):e4253. doi: 10.1371/journal.pone.0004253. Epub 2009 Jan 22.

DOI:10.1371/journal.pone.0004253
PMID:19158945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2617762/
Abstract

BACKGROUND

Friedreich ataxia originates from a decrease in mitochondrial frataxin, which causes the death of a subset of neurons. The biochemical hallmarks of the disease include low activity of the iron sulfur cluster-containing proteins (ISP) and impairment of antioxidant defense mechanisms that may play a major role in disease progression.

METHODOLOGY/PRINCIPAL FINDINGS: We thus investigated signaling pathways involved in antioxidant defense mechanisms. We showed that cultured fibroblasts from patients with Friedreich ataxia exhibited hypersensitivity to oxidative insults because of an impairment in the Nrf2 signaling pathway, which led to faulty induction of antioxidant enzymes. This impairment originated from previously reported actin remodeling by hydrogen peroxide.

CONCLUSIONS/SIGNIFICANCE: Thus, the defective machinery for ISP synthesis by causing mitochondrial iron dysmetabolism increases hydrogen peroxide production that accounts for the increased susceptibility to oxidative stress.

摘要

背景

弗里德赖希共济失调源于线粒体铁硫蛋白减少,这会导致一部分神经元死亡。该疾病的生化特征包括含铁硫簇蛋白(ISP)活性降低以及抗氧化防御机制受损,而抗氧化防御机制受损可能在疾病进展中起主要作用。

方法/主要发现:因此,我们研究了参与抗氧化防御机制的信号通路。我们发现,弗里德赖希共济失调患者的培养成纤维细胞由于Nrf2信号通路受损而对氧化损伤表现出超敏反应,这导致抗氧化酶的诱导出现故障。这种损伤源于先前报道的过氧化氢引起的肌动蛋白重塑。

结论/意义:因此,由线粒体铁代谢异常导致的ISP合成缺陷机制会增加过氧化氢的产生,这解释了对氧化应激易感性增加的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/d0d6a445c43e/pone.0004253.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/a6fcca61d7b4/pone.0004253.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/8d04f30747e1/pone.0004253.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/8e7c14aeed3d/pone.0004253.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/e464cca8235a/pone.0004253.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/51fbb5005c2b/pone.0004253.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/d0d6a445c43e/pone.0004253.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/a6fcca61d7b4/pone.0004253.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/8d04f30747e1/pone.0004253.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/8e7c14aeed3d/pone.0004253.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/e464cca8235a/pone.0004253.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/51fbb5005c2b/pone.0004253.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ef/2617762/d0d6a445c43e/pone.0004253.g006.jpg

相似文献

1
Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.核Nrf2易位受损会破坏弗里德赖希共济失调中的氧化应激反应。
PLoS One. 2009;4(1):e4253. doi: 10.1371/journal.pone.0004253. Epub 2009 Jan 22.
2
Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response.解析弗里德里希共济失调模型背根神经节中的铁死亡途径。LKB1/AMPK、KEAP1 和 GSK3β 在 NRF2 反应受损中的作用。
Redox Biol. 2024 Oct;76:103339. doi: 10.1016/j.redox.2024.103339. Epub 2024 Sep 4.
3
Friedreich ataxia: the oxidative stress paradox.弗里德赖希共济失调:氧化应激悖论
Hum Mol Genet. 2005 Feb 15;14(4):463-74. doi: 10.1093/hmg/ddi042. Epub 2004 Dec 22.
4
Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons.在培养的运动神经元中,铁调素缺乏会导致NF-E2相关因子(Nrf2)的表达降低和转运受损。
Int J Mol Sci. 2013 Apr 10;14(4):7853-65. doi: 10.3390/ijms14047853.
5
Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3β Axis.弗里德赖希共济失调小鼠心脏模型中的分子改变:通过上调Keap1和激活Gsk3β轴介导的Nrf2反应受损
Am J Pathol. 2017 Dec;187(12):2858-2875. doi: 10.1016/j.ajpath.2017.08.021. Epub 2017 Sep 19.
6
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia.Nrf2 诱导剂可抵抗铁蛋白沉默运动神经元中的神经变性:揭示弗里德里希共济失调的新治疗靶点。
Int J Mol Sci. 2017 Oct 18;18(10):2173. doi: 10.3390/ijms18102173.
7
The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich's Ataxia.NRF2 信号通路在弗里德里希共济失调中的临床生物标志物和治疗机会。
Int J Mol Sci. 2020 Jan 30;21(3):916. doi: 10.3390/ijms21030916.
8
Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs.靶向 NRF2 治疗弗里德赖希共济失调:药物比较。
Int J Mol Sci. 2019 Oct 21;20(20):5211. doi: 10.3390/ijms20205211.
9
Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.Exenatide 可诱导弗里德里希共济失调中的铁蛋白表达并改善线粒体功能。
JCI Insight. 2020 Jan 30;5(2):134221. doi: 10.1172/jci.insight.134221.
10
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.靶向弗里德赖希共济失调中的脂质过氧化和线粒体失衡。
Pharmacol Res. 2015 Sep;99:344-50. doi: 10.1016/j.phrs.2015.05.015. Epub 2015 Jul 2.

引用本文的文献

1
Frataxin: from the sequence to the biological role.铁调素:从序列到生物学作用
Biophys Rev. 2025 Apr 3;17(2):449-465. doi: 10.1007/s12551-025-01311-z. eCollection 2025 Apr.
2
Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk.弗里德赖希共济失调患者成纤维细胞中的氧化还原稳态与炎症:一种可能的相互作用。
Front Mol Neurosci. 2025 Apr 16;18:1571402. doi: 10.3389/fnmol.2025.1571402. eCollection 2025.
3
Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical Treatment.

本文引用的文献

1
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.抗氧化剂和吡格列酮(一种过氧化物酶体增殖物激活受体γ激动剂)可使老年阿尔茨海默病转基因小鼠的脑血管功能完全恢复。
J Neurosci. 2008 Sep 10;28(37):9287-96. doi: 10.1523/JNEUROSCI.3348-08.2008.
2
Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.弗里德赖希共济失调酵母模型中细胞色素铁硫蛋白缺乏细胞的谷胱甘肽依赖性氧化还原状态
Hum Mol Genet. 2008 Sep 15;17(18):2790-802. doi: 10.1093/hmg/ddn178. Epub 2008 Jun 18.
3
奥马伐醌治疗弗里德赖希共济失调的安全性监测:一年临床治疗结果
Neurol Ther. 2025 Jun;14(3):1105-1114. doi: 10.1007/s40120-025-00749-3. Epub 2025 Apr 30.
4
Brain microvascular endothelial cells differentiated from a Friedreich's Ataxia patient iPSC are deficient in tight junction protein expression and paracellularly permeable.从弗里德赖希共济失调患者诱导多能干细胞分化而来的脑微血管内皮细胞紧密连接蛋白表达不足且细胞旁通透性增加。
Front Mol Neurosci. 2025 Apr 15;18:1511388. doi: 10.3389/fnmol.2025.1511388. eCollection 2025.
5
A global perspective on research advances and future challenges in Friedreich ataxia.对弗里德赖希共济失调研究进展与未来挑战的全球视角。
Nat Rev Neurol. 2025 Apr;21(4):204-215. doi: 10.1038/s41582-025-01065-y. Epub 2025 Mar 3.
6
Clinical Assessment of the Drug-Drug Interaction Potential of Omaveloxolone in Healthy Adult Participants.奥马韦洛酮在健康成年受试者中药物相互作用潜力的临床评估。
J Clin Pharmacol. 2025 Jun;65(6):715-730. doi: 10.1002/jcph.6189. Epub 2025 Feb 7.
7
Biomarkers in Ataxia-Telangiectasia: a Systematic Review.共济失调毛细血管扩张症中的生物标志物:一项系统综述
J Neurol. 2025 Jan 15;272(2):110. doi: 10.1007/s00415-024-12766-7.
8
Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases.富马酸二甲酯的非Nrf2依赖性抗炎作用:开发用于神经退行性疾病的亲电子Nrf2激活剂所面临的挑战与前景。
Antioxidants (Basel). 2024 Dec 13;13(12):1527. doi: 10.3390/antiox13121527.
9
Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).奥马伐醌获批准用于治疗16岁及以上患有弗里德赖希共济失调(FRDA)的患者:美国医学遗传学与基因组学学会(ACMG)的一份治疗公报
Genet Med Open. 2023 Sep 9;1(1):100832. doi: 10.1016/j.gimo.2023.100832. eCollection 2023.
10
Skeletal Muscle Involvement in Friedreich Ataxia.弗里德里希共济失调中的骨骼肌受累。
Int J Mol Sci. 2024 Sep 13;25(18):9915. doi: 10.3390/ijms25189915.
Deferiprone targets aconitase: implication for Friedreich's ataxia treatment.
去铁酮作用于顺乌头酸酶:对弗里德赖希共济失调治疗的意义。
BMC Neurol. 2008 Jun 16;8:20. doi: 10.1186/1471-2377-8-20.
4
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria.PGAM5将包含Keap1和Nrf2的三元复合物连接到线粒体上。
Exp Cell Res. 2008 May 1;314(8):1789-803. doi: 10.1016/j.yexcr.2008.02.014. Epub 2008 Mar 5.
5
Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress.巨噬细胞中的抗氧化剂与二期酶:由Nrf2信号通路调控及对氧化应激和亲电应激的保护作用
Exp Biol Med (Maywood). 2008 Apr;233(4):463-74. doi: 10.3181/0711-RM-304.
6
Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases.真核生物中铁硫蛋白的成熟:机制、相关过程及疾病
Annu Rev Biochem. 2008;77:669-700. doi: 10.1146/annurev.biochem.76.052705.162653.
7
The mtDNA NARP mutation activates the actin-Nrf2 signaling of antioxidant defenses.
Biochem Biophys Res Commun. 2008 Apr 11;368(3):620-4. doi: 10.1016/j.bbrc.2008.01.125. Epub 2008 Feb 6.
8
Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia.过氧化氢清除作用挽救了弗里德赖希共济失调果蝇模型中的frataxin缺陷。
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):611-6. doi: 10.1073/pnas.0709691105. Epub 2008 Jan 9.
9
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.高剂量艾地苯醌对弗里德赖希共济失调患者的神经学影响:一项随机、安慰剂对照试验。
Lancet Neurol. 2007 Oct;6(10):878-86. doi: 10.1016/S1474-4422(07)70220-X.
10
Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia.弗里德赖希共济失调酵母模型中的氧化应激与蛋白酶功能障碍。
Free Radic Biol Med. 2007 May 15;42(10):1561-70. doi: 10.1016/j.freeradbiomed.2007.02.014. Epub 2007 Feb 28.